Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Kohl's Corporation (KSS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Kohl's Corporation — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Kohl's Corporation trades at $20.09 (market cap $2.28B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2.1× Kohl's Corporation's market cap, and Kohl's Corporation pays a 2.49% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Kohl's Corporation for 48 Days on average.
| DFTX | KSS | |
|---|---|---|
Market Cap | $4.71B | $2.28B |
Volume | 1,966,636 | 5,033,684 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $24.71 |
52-Week Low | $10.68 | $11.72 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $3.67B | $7.88B |
Dividend Yield | — | 2.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kohl's (KSS) trades at $20.10, up 2.39% with bullish technical momentum despite recent earnings beats showing mixed fundamentals. The company reported three consecutive quarterly earnings beats but faces declining revenue trends from $16.22B in 2025 to projected $15.4B in 2026. Valuation metrics appear attractive with P/E of 8.64 and P/B of 0.55, while technical indicators show strong bullish moving average signals but overbought RSI conditions.
KSS presents a value opportunity with deep discount valuations but carries execution risks amid persistent sales declines. The stock's 15.6% three-month rally faces sustainability questions as consumer spending shifts toward essentials. Analyst consensus remains cautious with 50% hold ratings and $15.50 price target below current levels, reflecting concerns about holiday execution and margin preservation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →
